COMMUNIQUÉS West-GlobeNewswire

-
FemPulse Announces Enrollment of First Participant in Clinical Study for Personalized Treatment of Overactive Bladder (OAB) in Women
15/07/2019 -
Therapeutic Solutions International adds Nano Cannabidiol to NanoMyros for Inhibition of Microvesicle and Exosome Release in Prostate Cancer
15/07/2019 -
Medical Marijuana Group Corporation Receives Processing and Sale for Medical Purposes License from Health Canada and Approval to Expand St Thomas Production Facility
15/07/2019 -
Share buy-back week 28/2019
15/07/2019 -
Endonovo Therapeutics Appoints Dr. Peter Novak to its Scientific Advisory Board
15/07/2019 -
Resverlogix Announces Publication on Apabetalone in Clinical Epigenetics
15/07/2019 -
Evolus Expands Board of Directors with Appointment of Independent Directors Peter Farrell, Ph.D. and Karah Parschauer, J.D.
15/07/2019 -
Caladrius Biosciences Receives Advanced Therapy Medicinal Product Classification for CLBS12, its CD34+ Cell Therapy for Critical Limb Ischemia
15/07/2019 -
Bhang Announces Joint Venture with Oceana Coffee for the Creation of Cannabidiol-infused and Terpene-infused Coffee Products
15/07/2019 -
Teneobio Doses First Patient in Phase 1 Study of TNB-383B for the Treatment of Patients with Multiple Myeloma
15/07/2019 -
HTG Expands RUO Profiling Menu with New Platform Compatibility Assays
15/07/2019 -
PetMed Express d/b/a 1-800-PetMeds to Announce Its First Quarter Financial Results on July 22, 2019
15/07/2019 -
Globus Medical Schedules Second Quarter 2019 Earnings Release and Conference Call
15/07/2019 -
Autoimmune Clinical Drug Development Expert, David J. Chang, M.D., M.P.H., Joins Cabaletta Bio as Chief Medical Officer
15/07/2019 -
Extendicare Announces July 2019 Dividend of C$0.04 per Share
15/07/2019 -
BioSig Technologies, Inc. to Receive 15 Units of PURE EP™ System from Manufacturer for Commercial Installation
15/07/2019 -
Imagin Medical Reports Progress in i/Blue™ Imaging System Functional Unit Development Phase
15/07/2019 -
Mereo BioPharma Announces Successful Type B Meeting with U.S. FDA and Outlines Accelerated Approval Pathway for Navicixizumab in Advanced Ovarian Cancer
15/07/2019 -
Daré Bioscience Announces Appointment of Dr. William H. Rastetter as Chairman of the Board of Directors
15/07/2019
Pages